| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Viral Carcinogenesis, National Cancer Institute, Frederick, Maryland 21701 [W. G. R., P. J. F.]; Department of Poultry Science, University of Maryland, College Park, Maryland 20724 [W. J. K.]; and Laboratory of Molecular Virology, National Cancer Institute, Bethesda, Maryland 20205 [G. F. V. W.]
The BALB/c murine endogenous xenotropic leukemia virus pseudotype of m1 Moloney sarcoma virus [m1MSV(B-MuX)] was used to productively transform diploid Japanese quail embryo cells. The majority of newly hatched quail inoculated with m1MSV(B-MuX)-transformed quail embryo fibroblast cells rapidly developed tumors which were predominantly locally invasive fibrosarcomas, but metastases were observed in two birds. In two tumor-bearing quail, lymphosarcomas were observed in conjunction with fibrosarcomas. Quail inoculated with m1MSV(B-MuX) virus or quail embryo fibroblast cells infected with helper leukemia virus did not develop tumors. A cell culture derived from one quail tumor was shown to be oncogenic in newly hatched quail.
Viruses produced by m1MSV(B-MuX)-infected quail cells or quail tumors had envelope properties of BALB-derived murine xenotropic leukemia virus as measured by host range, interference, and neutralization. Virus structural antigens, proteins with molecular weights of 30,000 and 70,000, were detected in tumors and tumor-derived cell lines by immunofluorescence and gel diffusion. Sera from tumored quail had high titers of type-specific BALB-derived murine xenotropic leukemia virus antibodies as determined by neutralization and immunoprecipitation. Antibodies to the putative m1 Moloney sarcoma virus mos gene product were not detected in sera from tumored or regressor quail.
1 To whom requests for reprints should be addressed.
Received 12/ 7/81. Accepted 3/18/82.
This article has been cited by other articles:
![]() |
N. Kan, G Franchini, F Wong-Staal, G. DuBois, W. Robey, J. Lautenberger, and T. Papas Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera Science, March 28, 1986; 231(4745): 1553 - 1555. [Abstract] [PDF] |
||||
![]() |
W. Robey, B Safai, S Oroszlan, L. Arthur, M. Gonda, R. Gallo, and P. Fischinger Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients Science, May 3, 1985; 228(4699): 593 - 595. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |